Colony Bankcorp, Inc.
NYSE:CBANBanks - Regional
+$0.01 today
- Market cap
- $542.11M
- Beta
- 0.55
- P/E (TTM)
- 14.6
- EPS (TTM)
- $1.41
- Dividend yield
- 2.29%
Volume 0.25M
Average 0.31M
CBAN Sales of Investments
Cash received from selling or redeeming investments.
Colony Bankcorp, Inc.NYSE: CBAN
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments growth accelerates
Q1 FY2026 sales of investments of $27.28M rose 26.6% year over year, ahead of the +20.6% change in trailing-twelve-month sales of investments. Sequentially, it rose 131.9% from the prior quarter. Over 3 fiscal years it compounded at +6.2% a year.
Context
- Sales of investments amounted to 84.0% of revenue in FY2025, up 15.9 pp from a year earlier.
- Sales of investments increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +26.6% holds above the trailing-twelve-month pace of +20.6%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 156.41M USD
- Year-over-year change
- +29.9%
- 4-year CAGR
- -6.1%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 156.41M | +29.9% |
| FY2024 | 2024-12-31 | 120.42M | +111.0% |
| FY2023 | 2023-12-31 | 57.08M | -56.3% |
| FY2022 | 2022-12-31 | 130.68M | -35.0% |
| FY2021 | 2021-12-31 | 201.14M | — |
Sales of Investments vs competitors
How CBAN compares with its peers on the latest reported figures
- CBAN's LTM Mar 2026 sales of investments of $137.59M is the 3rd largest of the 11 companies compared; the peer median is $78.02M.
- Its year-over-year change of +20.6% is the 5th highest of 10, against a peer median of +10.5%.
- Sales of investments amounts to 69.5% of revenue for CBAN, versus a peer median of 50.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $202.61M | +419.0% | +45.7% | 122.5% | |
| LTM Mar 2026 | $190.56M | +284.9% | +81.2% | 158.0% | |
| LTM Mar 2026 | $137.59M | +20.6% | +6.2% | 69.5% | |
| LTM Mar 2026 | $106.2M | +70.7% | +2.5% | 91.7% | |
| LTM Mar 2026 | $85.75M | +10.5% | +51.2% | 38.8% | |
| LTM Mar 2026 | $81.87M | — | +44.6% | 59.1% | |
| LTM Mar 2026 | $74.17M | -19.6% | +37.3% | 64.1% | |
| LTM Mar 2026 | $59.22M | +27.8% | -3.9% | 34.0% | |
| LTM Mar 2026 | $48.45M | +4.9% | -7.5% | 41.5% | |
| LTM Mar 2026 | $34.46M | +3.4% | -10.1% | 16.7% | |
| LTM Mar 2026 | $20.34M | -10.3% | +51.4% | 14.1% | |
| Peer median (excluding CBAN) | $78.02M | +10.5% | +40.9% | 50.3% | |
Competitors are the stored peer set for CBAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 18.66M | 19.54M | 21.75M | 23.87M | 28.25M |
| Depreciation & Amortization | 8.63M | 11.63M | 8.7M | 8.13M | 7.72M |
| Deferred Income Tax | (2.74M) | 1.13M | (485K) | 755K | 2.06M |
| Stock-Based Compensation | 599K | 1.74M | 1.7M | 1.3M | 785K |
| Change in Working Capital | (2.12M) | (7.95M) | (3.1M) | (2.01M) | (10.35M) |
| Accounts Receivables | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | (2.12M) | (7.95M) | (3.1M) | (2.01M) | (10.35M) |
| Other Non-Cash Items | 13.08M | 23.64M | (7.58M) | (8.64M) | (34.02M) |
| Operating Cash Flow | 36.1M | 49.74M | 20.98M | 23.4M | (5.55M) |
| Capital Expenditures | (5.84M) | (2.9M) | (3.62M) | (1.08M) | (1.35M) |
| Acquisitions (Net) | 33.3M | 0 | 0 | 0 | 916K |
| Purchases of Investments | (470M) | (174.22M) | (3.92M) | (56.62M) | (22.7M) |
| Sales of Investments | 201.14M | 130.68M | 57.08M | 120.42M | 156.41M |
| Other Investing Activities | 33.06M | (401.8M) | (148.3M) | 38.44M | (129.86M) |
| Investing Cash Flow | (208.33M) | (448.23M) | (98.75M) | 101.16M | 3.41M |
| Debt Repayment | (107.79M) | 114.01M | 35M | 9.5M | 0 |
| Common Stock Issued | 0 | 59.47M | 0 | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | (406K) | (1.31M) | (2.37M) |
| Dividends Paid | (4.46M) | (7.16M) | (7.72M) | (7.9M) | (8.04M) |
| Other Financing Activities | 298.21M | 115.62M | 53.54M | 22.86M | 39.15M |
| Financing Cash Flow | 185.95M | 281.93M | 80.41M | 23.15M | 28.74M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 13.73M | (116.55M) | 2.64M | 147.71M | 26.61M |
| Free Cash Flow | 30.27M | 46.85M | 17.37M | 22.32M | (6.9M) |
Colony Bankcorp, Inc.
NYSE:CBAN
Intrinsic Alpha fair value
Locked
Current Price
$19.86
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.